From: Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose
Time (h)
mean value ± s.d.
0.08
44 ± 12
0.60
46 ± 12
1.00
48 ± 12
2.00
53 ± 14
6.00
62 ± 12
12.0
69 ± 11